The Effect of Everolimus Initiation and Calcineurin Inhibitor Reduction on Allograft Vasculopathy in Maintenance Heart Transplant Recipients: Results of the NOCTET Trial After 5 Years

S. Arora ,1 K. Karason,2 H. Eisjaer,3 H. Botker,3 F. Gustafsson,4 K. Saunamaki,5 G. Radegran,6 E. Gude,1 L. Aaberge,1 T. Ueland,7 P. Aukrust,7 D. Solbu,8 L. Gullestad.1 1Cardiology, Oslo University Hospital, Rikshospitalet, Oslo, Norway; 2Cardiology, Sahlgrenska University Hospital, Gothenburg, Sweden; 3Cardiology, Skeiby University Hospital, Aarhus, Denmark; 4Cardiology, Rigshospitalet, Copenhagen, Djibouti; 5Cardiology, Rigshospitalet, Copenhagen, Denmark; 6Cardiology, Lund Hospital, Lund, Sweden; 7Research Institute for Internal Medicine, Oslo University Hospital, Rikshospitalet, Oslo, Norway; 8Novartis Norge, Oslo, Norway.